You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET-response adapted

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Sep 18, 2023

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Breast Cancer Trial in Shanghai (axillary surgery de-escalation after NAT)

Recruiting
  • Breast Cancer
  • axillary surgery de-escalation after NAT
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 13, 2023

Lymphoma, Non-Hodgkin's, Adult Trial in Rosario, Caba (Evaluation of first line treatment in patients with stage I and II LBCL)

Recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • Evaluation of first line treatment in patients with stage I and II LBCL
  • Paraná, Entre Ríos, Argentina
  • +6 more
Dec 29, 2022

Breast Cancer Trial in Worldwide (Perjeta, Herceptin, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Bruxelles, Belgium
  • +55 more
Jan 18, 2023

Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)

Recruiting
  • Hodgkin Lymphoma
  • Involved site radiotherapy
  • +6 more
  • Aberdeen, United Kingdom
  • +6 more
May 24, 2022

Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)

Withdrawn
  • Hodgkin Lymphoma
  • ABVD + FDG-PET/CT Scan treatment adaptation
  • BEACOPPesc
  • Copenhagen, Denmark
    Rigshospitalet
Feb 11, 2021

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Moscow, Russian Federation
    National Research Center for Hematology
Dec 13, 2022

Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

Not yet recruiting
  • Hodgkin Lymphoma
  • Tislelizumab, AVD, Radiotherapy
  • (no location specified)
Nov 15, 2022

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)

Active, not recruiting
  • Lymphoma
  • bleomycin sulfate
  • +10 more
  • Southampton, England, United Kingdom
    Southampton General Hospital
Apr 27, 2021

Multiple Myeloma Trial (Continued treatment adapted to the response)

Completed
  • Multiple Myeloma
  • Continued treatment adapted to the response
  • (no location specified)
Jan 14, 2023

Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)

Active, not recruiting
  • Hodgkin Lymphoma
  • Alessandria, Italy
  • +45 more
Dec 22, 2022

Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)

Not yet recruiting
  • Lymphoma
  • Ultra Low Dose 4 Gy Radiation
  • (no location specified)
Jun 30, 2023

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Chronic Lymphocytic Leukemia Trial (Evaluation of response to treatment with response-tailored Ibrutinib in patients with

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Evaluation of response to treatment with response-tailored Ibrutinib in patients with chronic lymphocytic leukemia
  • (no location specified)
Dec 27, 2022

Therapy Using 18F-FSPG PET

Not yet recruiting
  • Cancer
  • +3 more
  • 18F-FSPG PET/CT in NSCLC
  • 18F-FSPG PET/CT in HNSCC
  • (no location specified)
May 24, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Response After Neoadjuvant Treatment of Locally Advanced Rectal

Not yet recruiting
  • Rectal Cancer
  • PET-MRI
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • ctDNA Blood Test
  • +8 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University
Feb 8, 2023

Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)

Not yet recruiting
  • Prostate Adenocarcinoma
  • 68-Ga PSMA11
  • Dallas, Texas
    UT Southwestern Medical Center
Sep 12, 2023

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Castration Sensitive Prostate Cancer
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 16, 2023

Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

Recruiting
  • Rectal Cancer
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 11, 2023